Lerma

Test Your Knowledge: Dysproteinemic Kidney Diseases

December 9, 2019 // 0 Comments

A recent AJKD Core Curriculum by Hogan et al reviews the pathogenesis, diagnosis, and treatment of dysproteinemic kidney diseases. Test your knowledge on this topic with the quiz below. For a PDF version of the questions & answers, please click [read more...]

#KidneyWk 2019: Pain Management in ESKD

November 21, 2019 // 0 Comments

The “Nephrology Quiz and Questionnaire 2019” session was held on Nov 7, 2019, at the ASN #KidneyWk in Washington, DC. Click here for more KidneyWk 2019 coverage on AJKD Blog. This is Part 3 of the Kidney STARS’ write-up of KidneyWk [read more...]

#KidneyWk 2019: Intermittent Fasting and Kidney Disease

November 20, 2019 // 0 Comments

The “Linking Lifestyle, BP, and Kidney Diseases: What Is the Evidence?” session was held on Nov 7, 2019, at the ASN #KidneyWk in Washington, DC. Click here for more KidneyWk 2019 coverage on AJKD Blog. This is Part 2 of the Kidney [read more...]

#KidneyWk 2019 – Acute Interstitial Nephritis

November 19, 2019 // 0 Comments

The “Drilling Down on Acute Interstitial Nephritis” session was held on Nov 8, 2019, at the ASN #KidneyWk in Washington, DC. I had the distinct opportunity of meeting some of the very talented participants of the ASN Kidney STARS. The program [read more...]

Utility of Hypertonic Mannitol for the Prevention of Intradialytic Hypotension (IDH)

October 7, 2019 // 0 Comments

Intradialytic hypotension (IDH) is sometimes defined as a decrease in systolic BP by ≥20 mm Hg or a decrease in mean arterial pressure of 10 mm Hg associated with symptoms. There are, however, other definitions of IDH in the literature. Whereas [read more...]

Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3 CKD

August 15, 2019 // 1 Comment

There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the treatment of type 2 diabetes mellitus (T2DM). Studies such as CANVAS allude to their glucose-lowering [read more...]

Clinical Trial End Points in ADPKD

June 6, 2019 // 0 Comments

Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. There has been recent interest in redefining end points for clinical trials [read more...]

#KidneyWk 2017: KDIGO Guideline and Conference Updates

November 28, 2017 // 0 Comments

As KDIGO Social Media Ambassador, I always make it a point to attend the KDIGO Guideline and Conference Updates at Kidney Week. It always provides a nice compendium of updates of KDIGO guidelines. In 2013, KDIGO convened a Controversies Conference [read more...]

Mediterranean Diet and Risk of Nephrolithiasis

October 24, 2017 // 1 Comment

As a clinician, it is not uncommon for me to see a patient, a colleague, a friend, or even a family member who had a recent or previous bout of a kidney stone. Nephrolithiasis is a common problem encountered not only in the nephrology office but [read more...]

NephMadness 2016: Let the Madness Begin

March 10, 2016 // 1 Comment

What is NephMadness? NephMadness is an homage to the NCAA Basketball Tournament, March Madness, but while the basketball tournament seeds the top ranked basketball teams, we use some of the most important, newest, and controversial concepts in [read more...]